Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04448704|
Recruitment Status : Recruiting
First Posted : June 26, 2020
Last Update Posted : June 30, 2020
|Condition or disease|
|Mental Health Issue|
Worldwide, there are an estimated 164 million migrant workers. Although studies have documented how workers have an increased risk of adverse health outcomes, little is known about their vulnerability during a health crisis.
In the current COVID-19 outbreak, nearly 30,000 migrant workers have been infected with SARS-CoV-2 in Singapore. This represents 9 in 10 of the local cases, and 25 dormitories have been gazetted to contain the spread of the virus. Correspondingly, these measures have placed a spotlight on the well-being of migrant workers.
In this research protocol, the investigators propose to administer a survey to understand the mental health of migrant workers: (1) diagnosed with COVID-19 (housed in NUS or Expo), and (2) quarantined in dormitories. This will allow the investigators to capture the base rate of depression, anxiety, and stress symptoms in the population, and will also help to identify risk factors of psychological distress within this population.
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak|
|Actual Study Start Date :||June 22, 2020|
|Estimated Primary Completion Date :||September 30, 2020|
|Estimated Study Completion Date :||December 31, 2020|
- DASS-21 Scores [ Time Frame: single measurement upon study enrolment ]Depression, Anxiety and Stress Scale (DASS-21) is a validated 21-item measure that has been widely used during the current crisis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04448704
|Contact: Jean Liu, PhD||+65 9223 email@example.com|
|Contact: Edina Tanfirstname.lastname@example.org|